The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
Move to accelerate cancer care expansion across India
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Subscribe To Our Newsletter & Stay Updated
